Docosahexaenoic acid ethyl ester/Eicosapentaenoic acid ethyl ester

二十碳五烯酸乙酯/二十二碳六烯酸乙酯

Report date: 2023/05/24 20:00:35

Base Information

Drug NameDocosahexaenoic acid ethyl ester/Eicosapentaenoic acid ethyl ester
Drug Alias NameEicosapentaenoic acid ethyl ester/ acid ethyl ester二十二碳六烯酸乙酯+二十碳五烯酸乙酯二十二碳六烯酸乙酯/二十碳五烯酸乙酯二十碳五烯酸乙酯+二十二碳六烯酸乙酯SC-401B +[6] 
ClassificationSmall molecules
Mechanisms of ActionPeroxisome proliferator-activated receptor α agonists
TargetsPeroxisome proliferator-activated receptor α
Therapy Area/IndicationsHypertriglyceridemiaBrain Injuries, Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMicelle Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSancilio And Company IncUniversity Of Michigan
Active IndicationsN/A
Inactive IndicationsHypertriglyceridemiaBrain Injuries, Traumatic

Other Information

ATC CodeN/A
Related LinksN/A